2018 annual financial data

Prelude Therapeutics Incorporated 2018 Operating margin

Prelude Therapeutics Incorporated 2018 operating margin with verified reported…

Direct answer

Operating margin was Not calculable.

Operating income was -14,975,000 USD and net income was -14,680,000 USD.
Operating cash flow was -12,954,000 USD.

Get free Prelude Therapeutics Incorporated email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-14,975,000 USD
Net income
-14,680,000 USD
Operating cash flow
-12,954,000 USD